Medical Equipment

Global Head And Neck Cancer Diagnostics Market Valuation and Growth Prospects: $3.83 Billion by 2029

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the head and neck cancer diagnostics market from 2025–2034 with trusted insights from The Business Research Company

What Are The Future Growth Projections For The Head And Neck Cancer Diagnostics Market Size?

The head and neck cancer diagnostics market size has experienced swift expansion in recent years. It is anticipated to grow from $1.74 billion in 2024 to $2.03 billion in 2025, achieving a compound annual growth rate (CAGR) of 16.6%. This historic growth is largely attributable to tobacco and alcohol consumption, a rising aging population, various awareness campaigns, advancements in biopsy techniques, and improvements in healthcare infrastructure.

The head and neck cancer diagnostics market size is anticipated to experience substantial growth over the next few years. It is predicted to expand to $3.83 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 17.2%. The expansion during this forecast period can be primarily linked to genomic biomarkers, the increasing occurrence of HPV-related cancers, the incorporation of artificial intelligence (AI), the progress in immunotherapy and targeted therapies, and changes in healthcare policies and reimbursement. Significant developments anticipated in this period include the leading role of liquid biopsy, the rise of multi-modality diagnostics, the increasing use of point-of-care diagnostics, enhanced global collaborations and partnerships, and the integration of digital pathology.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12016&type=smp

What Core Market Drivers Are Expanding The Head And Neck Cancer Diagnostics Industry?

The rising occurrence of head and neck cancer is anticipated to drive expansion in the head and neck cancer diagnostics market moving forward. Head and neck cancer encompasses a range of tumors that impact the tissues and organs within the head and neck region. These types of cancer involve areas such as the mouth, pharynx, larynx, salivary glands, nasal cavity, and sinuses. Diagnostic tools for head and neck cancer assist patients in early detection through various examinations, such as an incisional biopsy and a barium swallow test. For example, in February 2023, data from the American Society of Clinical Oncology, a professional organization for oncology specialists based in the US, indicated that head and neck cancer constituted 4% of all cancers in the US. Projections suggest that 66,920 individuals in the USA will be affected by head and neck cancer in 2023 (comprising 49,190 men and 17,730 women). Globally, 562,328 people were impacted by head and neck cancer in 2020. Moreover, head and neck cancer statistics for Australia reported 5,189 new cases in 2022. Consequently, the increasing incidence of head and neck cancer is fueling the growth of the head and neck cancer diagnostics market.

What Segment Insights Are Highlighted In The Head And Neck Cancer Diagnostics Market Report?

The head and neck cancer diagnosticsmarket covered in this report is segmented –

1) By Diagnostic Method: Diagnostic Imaging Equipment, Endoscopy Screening Equipment, Biopsy Screening Tests, Dental Diagnostic Methods, Other Diagnostic Methods

2) By Channel: Retail And Specialty Pharmacies, Hospital Pharmacies, Online Pharmacies

3) By End-User: Hospitals, Diagnostic Centers, Other End Users

Subsegments:

1) By Diagnostic Imaging Equipment: Computed Tomography (CT) Scans, Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET) Scans, X-rays

2) By Endoscopy Screening Equipment: Rigid Endoscopes, Flexible Endoscopes, Video Endoscopy Systems

3) By Biopsy Screening Tests: Fine Needle Aspiration (FNA) Biopsy, Core Needle Biopsy, Surgical Biopsy

4) By Dental Diagnostic Methods: Intraoral Cameras, Dental X-rays, Oral Cancer Screening Devices

5) By Other Diagnostic Methods: Molecular Diagnostics, Blood Tests, Genetic Testing

Which Notable Trends Are Transforming The Head And Neck Cancer Diagnostics Market Outlook?

Product innovation has emerged as a key trend gaining popularity in the head and neck cancer diagnostic market. Major market players are concentrating their efforts on creating innovative products to strengthen their position in the market. For instance, in May 2023, Alkem Laboratories Ltd., an India-based healthcare company, launched Cetuxa, the world’s first biosimilar for head and neck cancer treatment. Cetuxa is biosimilar to cetuximab, a monoclonal antibody that inhibits the receptor-dependent transduction pathway and has anti-tumor properties. Cetuximab binds to the epidermal growth factor receptor (EGFR)’s extracellular domain. Chemotherapy or radiation therapy is frequently combined with cetuximab in clinical practice. It may be used to treat squamous cell carcinoma of the head and neck that is locally advanced, recurring, or metastatic.

Which Firms Are Driving Innovation Within The Head And Neck Cancer Diagnostics Market?

Major companies operating in the head and neck cancer diagnostics market include F. Hoffmann-La Roche Ltd., Bristol Myers Squibb Co., Abbott Laboratories, Siemens Healthineers AG, BioNTech AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Laboratory Corporation of America, Agilent Technologies Inc., Hologic Inc., Illumina Inc., Shimadzu Corporation, Sysmex Corp., Varian Medical Systems Inc., QIAGEN N.V., Exact Sciences Corp., Bio-Techne Corp., Carestream Health Inc., Myriad Genetics Inc., Cepheid Inc., Invitae Corporation, Accuray Inc., Canon Medical Systems Corporation, NanoString Technologies Inc, Asuragen Inc., Caris Life Sciences Inc., HTG Molecular Diagnostics Inc., Oncgnostics GmbH, Perseus Proteomics Inc., VolitionRx Ltd.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/head-and-neck-cancer-diagnostics-global-market-report

What Regional Trends Are Shaping Growth In The Head And Neck Cancer Diagnostics Market?

North America was the largest region in the head and neck cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the head and neck cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=12016&type=smp

Browse Through More Reports Similar to the Global Head And Neck Cancer Diagnostics Market 2025, By The Business Research Company

Epoxy Resin Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/epoxy-resin-global-market-report

Epoxy Adhesives Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/epoxy-adhesives-global-market-report

Chemical Logistics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/chemical-logistics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795